| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/18/2000 | WO2000027382A2 Combination of a gaba-a alpha 5 inverse agonist and cox-2 inhibitor, nsaid, estrogen or vitamin e |
| 05/18/2000 | WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | WO2000027377A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 05/18/2000 | WO2000027372A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 05/18/2000 | WO2000027363A1 Aerosols comprising nanoparticle drugs |
| 05/18/2000 | WO2000027359A1 An inhalation system |
| 05/18/2000 | WO2000027205A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization |
| 05/18/2000 | WO2000010553A3 Carbamate and urea compositions and neurotrophic uses |
| 05/18/2000 | WO2000009139A3 Methods for promoting survival of myelin producing cells |
| 05/18/2000 | WO2000009130A3 New pharmaceutical uses for nos inhibitors |
| 05/18/2000 | WO2000009108A3 Compositions and uses for vision and memory disorders |
| 05/18/2000 | WO2000006140A3 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 05/18/2000 | WO2000003740A3 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia |
| 05/18/2000 | WO1999058096A3 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 05/18/2000 | CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine |
| 05/18/2000 | CA2351057A1 Combination of a gaba-a alpha 5 inverse agonist and cox-2 inhibitor, nsaid, estrogen or vitamin e |
| 05/18/2000 | CA2350714A1 Spiro-indolines as y5 receptor antagonists |
| 05/18/2000 | CA2350642A1 Crf receptor antagonists and methods relating thereto |
| 05/18/2000 | CA2350429A1 Neurotrophic diamide and carbamate agents |
| 05/18/2000 | CA2350388A1 Human hydrolase proteins |
| 05/18/2000 | CA2350304A1 Dispersible compositions containing l-dopa ethyl ester |
| 05/18/2000 | CA2350183A1 Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells |
| 05/18/2000 | CA2350133A1 A method for treating tissue damaged from ischemia |
| 05/18/2000 | CA2349904A1 Crf receptor antagonists and methods relating thereto |
| 05/18/2000 | CA2349700A1 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 05/18/2000 | CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/18/2000 | CA2349496A1 Delivery of superoxide dismutase to neuronal cells |
| 05/18/2000 | CA2349449A1 Cell surface glycoproteins |
| 05/18/2000 | CA2349245A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 05/18/2000 | CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | CA2348934A1 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2346108A1 Gastrin and cholecystokinin receptor ligands |
| 05/17/2000 | EP1001023A2 Frizzled-4, a putative Wnt-receptor |
| 05/17/2000 | EP1000944A1 Crystalline nefazodone hydrochloride dihydrate and process for the preparation thereof |
| 05/17/2000 | EP1000930A2 Tachykinin antagonists |
| 05/17/2000 | EP1000927A2 Excitatory amino acid receptor modulators |
| 05/17/2000 | EP1000621A2 Use of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (CD) indoles for treating motion sickness and vomiting |
| 05/17/2000 | EP1000618A1 Topical capsaicin preparation |
| 05/17/2000 | EP1000166A2 Inhibitors of cell-cycle progression and uses related thereto |
| 05/17/2000 | EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues |
| 05/17/2000 | EP1000084A1 123 human secreted proteins |
| 05/17/2000 | EP1000067A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 05/17/2000 | EP1000066A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 05/17/2000 | EP1000065A1 Preparation of oxymorphone, oxycodone and derivatives |
| 05/17/2000 | EP1000064A1 Compounds |
| 05/17/2000 | EP1000063A1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO 4,5-$i(b)]-INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY |
| 05/17/2000 | EP1000061A1 Therapeutically active 1,2,4-triazolo(4,3-b) pyridazine derivatives as ligands for gaba receptors |
| 05/17/2000 | EP1000056A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 05/17/2000 | EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/17/2000 | EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 05/17/2000 | EP1000047A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 05/17/2000 | EP1000046A1 Piperazine derivatives active on the lower urinary tract |
| 05/17/2000 | EP1000043A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 05/17/2000 | EP1000035A1 Substituted 6-phenylphenanthridines |
| 05/17/2000 | EP1000034A1 Substituted 6-alkylphenanthridines |
| 05/17/2000 | EP1000017A1 Il-8 receptor antagonists |
| 05/17/2000 | EP1000015A1 Bicyclic metabotropic glutamate receptor ligands |
| 05/17/2000 | EP1000008A1 Novel thyroid receptor ligands and method |
| 05/17/2000 | EP0999846A1 Phosphatidic acid-based immune modulator composition |
| 05/17/2000 | EP0999842A1 Novel substituted imidazole compounds |
| 05/17/2000 | EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 05/17/2000 | EP0999840A1 Use of draflazine-analogues for treating pain |
| 05/17/2000 | EP0999839A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 05/17/2000 | EP0999830A1 Sertraline salts and sustained-release dosage forms of sertraline |
| 05/17/2000 | EP0999757A1 Nutritional composition for subjects under stress |
| 05/17/2000 | EP0770066B1 Serotonin 5-ht 1a and dopamin d2 receptor ligands |
| 05/17/2000 | EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/17/2000 | CN1253554A Heterocyclic compounds and their use for inhibiting 'beta'-amyloid peptide |
| 05/17/2000 | CN1253551A Pyrazine compounds |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/17/2000 | CN1253501A IL-8 receptor antagonists |
| 05/17/2000 | CN1253497A Swallow tablet comprising paracetamol |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/17/2000 | CN1253015A Massage liquid for giving up smoking and its preparing process |
| 05/17/2000 | CN1052411C Powder medicine of taking with water for curing head pain |
| 05/17/2000 | CN1052402C Oligosaccharid type antipsychotic |
| 05/17/2000 | CN1052400C 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzole as anti-depression medicine |
| 05/16/2000 | US6063927 Paroxetine derivatives |
| 05/16/2000 | US6063903 Ligands for EPH-like receptors |
| 05/16/2000 | US6063817 Antiischemic agents |
| 05/16/2000 | US6063810 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 05/16/2000 | US6063807 Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 05/16/2000 | US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor |
| 05/16/2000 | US6063796 Heterocyclic compounds of piperidine |
| 05/16/2000 | US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use |
| 05/16/2000 | US6063784 Heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists |
| 05/16/2000 | CA2180263C Diazabicyclic neurokinin antagonists |
| 05/11/2000 | WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026252A1 Compounds with growth hormone releasing properties |
| 05/11/2000 | WO2000026251A2 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |